Mountain Hill Investment Partners Corp. Biogen Inc. Transaction History
Mountain Hill Investment Partners Corp.
- $102 Billion
- Q1 2025
A detailed history of Mountain Hill Investment Partners Corp. transactions in Biogen Inc. stock. As of the latest transaction made, Mountain Hill Investment Partners Corp. holds 75 shares of BIIB stock, worth $9,473. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75
Previous 150
50.0%
Holding current value
$9,473
Previous $22.9 Million
55.26%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,026Shares Held
127MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.15 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2.01 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.84 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$934 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$590 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...